Biologic drugs continue to be one of the fastest-growing categories of the pharmaceutical market. US sales of biologics grew 9.7% annually from 2010 to 2012 to $65.5 billion, or 47% of the global market, according to EvaluatePharma. According to the Pharmaceutical Research and Manufacturers of America, 907 biologic medicines and vaccines are in development at […]
In April, Waters announced the NuGenesis Lab Management System, an update to NuGenesis 8, released in 2012. Like the previous version, the product features a Scientific Data Management System (SDMS), ELN and laboratory execution system. The system bypasses elements of LIMS, such as invoicing and trend analysis, that many labs do not require. Waters Senior […]
In June, the NIH’s Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Working Group to the Advisory Committee released “BRAIN 2025: A Scientific Vision,” a report on its findings and recommendations. The Group was formed to develop a plan to advance President Obama’s BRAIN Initiative, which was announced last year (see IBO 4/15/13). Last fall, the […]
First quarter Life Science Index sales grew 5.0%, 7.1% on a currency-neutral basis, to $3,387 million. Index sales were driven by double-digit organic revenue growth each for Illumina, Fluidigm, BD Biosciences and Biotage. Operating profit climbed 11.0% to $719 million. Based on current operations, operating margin expanded 90 basis points to 19.4% of sales. Of […]
With the exception of several younger companies, the majority of analytical instrument and lab product companies in the table on page 4 recorded modest sales-per-employee growth in fiscal year 2013 (FY13). The average sales-per-employee ratio for the 18 companies grew 3.6% excluding currency to $319,284 in FY13. However, due to increased investments, acquisitions or slow […]
The study of cells has been instrumental in understanding biological processes. Research on genes and proteins expressed in specific types of cells has typically been performed on samples containing many cells, with analysis reflecting the data averaged across them. But recent studies have indicated differences in cells of the same type or within the same […]
Despite a downward revision to the first quarter US GDP to negative 1.0% and further mixed economic data, the Dow Jones Industrial Average and S&P 500 gained 0.8% and 2.1% in May, respectively, to close at record highs. The NASDAQ rebounded 3.1% following losses in the previous two months. For the first quarter, the Dow, […]
The calendar year first quarter provided few clear trends as large publicly held US analytical and life science instrument firms experienced mixed results, with strengths and weaknesses in market and geographic segments varying by company. The six laboratory instrument and product businesses whose quarterly revenues are detailed on pages 9–11 reported positive sales results for […]
Thermo Fisher Scientific and Life Technologies made their financial-reporting debut as one company (see IBO 4/15/13) with the release of Thermo’s first quarter earnings in April. The industry-changing acquisition united two of the top five analytical and life science instrument firms (see IBO 4/15/14), creating a company whose financial size and breadth of products dwarf […]
First quarter revenue growth for IBO’s Laboratory Instrument Sales Index jumped 7.3%, 6.8% excluding currency, to $6,308 million. Adjusted operating profit advanced 13.5% to $1,376 million, and operating margin expanded 20 basis points to 18.3% of sales. Financial estimates are included for Oxford Instruments, Spectris and Tecan, which have yet to report first quarter financial […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
